Repurposing an FDA-Approved Drug to Inhibit Bacterial Protein Toxins

被引：0
|
作者：
Borho, J. [1 ]
Eckert, A. [1 ]
Koegel, M. [1 ]
Barth, H. [1 ]
机构：
[1] Univ Ulm Med Ctr, Inst Expt & Clin Pharmacol, Toxicol & Pharmacol Nat Prod, Ulm, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2024年 / 397卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P061
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [31] Deuterated Drug Molecules: Focus on FDA-Approved Deutetrabenazine
    DeWitt, Sheila H.
    Maryanoff, Bruce E.
    BIOCHEMISTRY, 2018, 57 (05) : 472 - 473
  • [32] Miltefosine, an FDA-approved drug for the 'orphan disease', leishmaniasis
    Berman, Jonathan
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (06): : 727 - 735
  • [33] The FDA-Approved Drug Apremilast Suppresses Alcohol Intake
    Ozburn, Angela
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 38 - 38
  • [34] Novel FDA-approved zavegepant drug for treating migraine
    Ahmed, Usaid
    Saleem, Muhammad Meeran
    Osman, Mohamed Ashraf
    Shamat, Shamat Fathi
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (02): : 923 - 925
  • [35] Ocular toxicities of FDA-approved antibody drug conjugates
    Vetsa, Shaurey
    Zhang, Stephanie
    Kay, Walker
    Kelkar, Neil
    Ghosh, Arko
    Alam, Suhail
    Hoopes, Phillip C.
    Moshirfar, Majid
    CUTANEOUS AND OCULAR TOXICOLOGY, 2024, 43 (04) : 316 - 327
  • [36] QUADrATiC: Scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
    O'Reilly, Paul G.
    Wen, Qing
    Bankhead, Peter
    Dunne, Philip D.
    McArt, Darragh G.
    McPherson, Suzanne
    Hamilton, Peter W.
    Mills, Ken I.
    Zhang, Shu-Dong
    BMC Bioinformatics, 2016, 17 (01):
  • [37] Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis
    Rani, Jyoti
    Silla, Yumnam
    Borah, Kasmika
    Ramachandran, Srinivasan
    Bajpai, Urmi
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (09): : 2521 - 2532
  • [38] In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
    Salaam, Ridwan Abiodun
    Afolayan, Funmilayo I. D.
    Olaniyi, Damilare Adebayo
    Oladokun, Sayo Ebenezer
    Ebuh, Rachael Pius
    Oyetunji, Ridwan Abiola
    SCIENTIFIC AFRICAN, 2025, 27
  • [39] Structure-Based Repurposing of FDA-Approved Drugs as TNF-α Inhibitors
    Leung, Chung-Hang
    Chan, Daniel Shiu-Hin
    Kwan, Maria Hiu-Tung
    Cheng, Zhen
    Wong, Chun-Yuen
    Zhu, Guo-Yuan
    Fong, Wang-Fun
    Ma, Dik-Lung
    CHEMMEDCHEM, 2011, 6 (05) : 765 - 768
  • [40] Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
    Abutaleb, Nader S.
    Elhassanny, Ahmed E. M.
    Nocentini, Alessio
    Hewitt, Chad S.
    Elkashif, Ahmed
    Cooper, Bruce R.
    Supuran, Claudiu T.
    Seleem, Mohamed N.
    Flaherty, Daniel P.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 51 - 61
12345